MMMarlina Olyissa Córdoba Moreno

Marlina Olyissa Córdoba Moreno

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marlina Olyissa Córdoba Moreno has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • IL‐10‐induced STAT3/NF‐κB crosstalk modulates pineal and extra‐pineal melatonin synthesis

    by Marlina O. Córdoba‐Moreno, Gabriela Christine Santos, Sandra M. Muxel, Débora dos Santos‐Silva, Caroline L. Quiles, Kassiano D. S. Sousa, Regina P. Markus, Pedro Augusto C. M. Fernandes

    Immune‐pineal axis activation is part of the assembly of immune responses. Proinflammatory cytokines inhibit the pineal synthesis of melatonin while inducing it in macrophages by mechanisms dependent on nuclear factor‐κB (NF‐κB) activation. Cytokines activating the Janus kinase/signal transducer and activator of transcription (STAT) pathways, such as interferon‐gamma (IFN‐γ) and interleukin‐10 (IL‐10), modulate melatonin synthesis in the pineal, bone marrow (BM), and spleen. The stimulatory effect of IFN‐γ upon the pineal gland depends on STAT1/NF‐κB interaction, but the mechanisms controlling IL‐10 effects on melatonin synthesis remain unclear. Here, we evaluated the role of STAT3 and NF‐κB activation by IL‐10 upon the melatonin synthesis of rats' pineal gland, BM, spleen, and peritoneal cells. The results show that IL‐10‐induced interaction of (p)STAT3 with specific NF‐κB dimmers leads to different cell effects. IL‐10 increases the pineal's acetylserotonin O‐methyltransferase (ASMT), N‐acetylserotonin, and melatonin content via nuclear translocation of NF‐κB/STAT3. In BM, the nuclear translocation of STAT3/p65‐NF‐κB complexes increases ASMT expression and melatonin content. Increased pSTAT3/p65‐NF‐κB nuclear translocation in the spleen enhances phosphorylated serotonin N‐acetyltransferase ((p)SNAT) expression and melatonin content. Conversely, in peritoneal cells, IL‐10 leads to NF‐κB p50/p50 inhibitory dimmer nuclear translocation, decreasing (p)SNAT expression and melatonin content. In conclusion, IL‐10's effects on melatonin production depend on the NF‐κB subunits interacting with (p)STAT3. Thus, variations of IL‐10 levels and downstream pathways during immune responses might be critical regulatory factors adjusting pineal and extra‐pineal synthesis of melatonin.


  • Rat resistance to rheumatoid arthritis induction as a function of the early‐phase adrenal–pineal crosstalk

    by Marlina O. Córdoba‐Moreno, Mariana Trivilin Mendes, Regina P. Markus, Pedro Augusto Fernandes

    Chronic inflammatory diseases are triggered by causal stimuli that might occur long before the appearance of the symptoms. Increasing evidence suggests that these stimuli are necessary but not always sufficient to induce the diseases. The murine model of type II collagen emulsified in Freund's incomplete adjuvant (collagen-induced arthritis) to induce rheumatoid arthritis (RA) follows this pattern as some animals do not develop the chronically inflamed phenotype. Considering that in the immune-pineal axis (IPA) theory adrenal-pineal cross-talk adjusts early phases of inflammatory processes, we investigated whether differences in IPA activation could explain why some animals are resistant (RES) while others develop RA. We observed a similar increase in 6-sulfatoxymelatonin (aMT6s) excretion from day 3 to 13 in both RES and RA animals, followed by a significant decrease in RA animals. This pattern of aMT6s excretion positively correlated with plasma corticosterone (CORT) in RES animals. Additionally, RA animals presented a lower aMT6s/CORT ratio than saline-injected or RES animals. Plasmatic levels of tumour necrosis factor were similar in both groups, but interleukin (IL)-1 beta and monocyte chemotactic protein 1 (MCP-1) levels were lower in RES compared to RA animals. IL-2 and IL-4 were decreased in RES animals compared to saline-injected animals. The aMT6s/CORT ratio inversely correlated with the paw thickness and the inflammatory score (levels of IL-1 beta, MCP-1, IL-2 and IL-4 combined). Thus, adrenocortical-pineal positive interaction is an early defence mechanism for avoiding inflammatory chronification. Abstract figure legend Adrenal-pineal crosstalk provides resistance to RA development in rats. Left, resistance:moderately increased CORT levels lead to glucocorticoid receptor stimulation in the pineal gland, counteracting TNF inhibitory effect and potentiating beta 1-adrenoreceptor-induced pineal melatonin production. Increased melatonin levelsassociated with corticosterone reduce cellular migration, regulating an appropriate synovial cellular infiltration and thesynthesis of cytokines composing the inflammatory score. Right, rheumatoid arthritis: highly elevated corticosteronelevels combined with beta 1-+alpha 1-adrenoceptor activation and circulating TNF reduces the synthesis of melatonin bythe pineal gland. Lower circulating melatonin levels lead to increased synovial cellular infiltration. Infiltrated cells,resident fibroblasts and resident macrophages produce large amounts of inflammatory factors, leading to chronicinflammation. The data provide evidence that an unbalanced immune-pineal axis activation lies at the point of originof RA development (Markus et al. 2021). Figure produced with BioRender.com Key points Immune-pineal axis imbalance is observed in early-phase rheumatoid arthritis development.Only resistant animals present a positive association between adrenal and pineal hormones.The 6-sulfatoxymelatonin/corticosterone ratio is decreased in animals that develop rheumatoid arthritis.The inflammatory score combining the levels of nocturnal interleukin (IL)-1 beta, monocyte chemotactic protein 1, IL-2 and IL-4 presents a very strong positive correlation with the size of inflammatory lesion.The 6-sulfatoxymelatonin/corticosterone ratio presents a strong negative correlation with the inflammatory score and paw oedema size.


  • Open Access

    Rhythmic expression of the melatonergic biosynthetic pathway and its differential modulation in vitro by LPS and IL10 in bone marrow and spleen

    by Marlina O. Córdoba-Moreno, Ewerton da Silva de Souza, Caroline L. Quiles, Débora dos Santos-Silva, Gabriela S. Kinker, Sandra M. Muxel, Regina P. Markus, Pedro A. Fernandes

    Daily oscillation of the immune system follows the central biological clock outputs control such as melatonin produced by the pineal gland. Despite the literature showing that melatonin is also synthesized by macrophages and T lymphocytes, no information is available regarding the temporal profile of the melatonergic system of immune cells and organs in steady-state. Here, the expression of the enzymes arylalkylamine-N-acetyltransferase (AA-NAT), its phosphorylated form (P-AA-NAT) and acetylserotonin-O-methyltransferase (ASMT) were evaluated in phagocytes and T cells of the bone marrow (BM) and spleen. We also determined how the melatonergic system of these cells is modulated by LPS and the cytokine IL-10. The expression of the melatonergic enzymes showed daily rhythms in BM and spleen cells. Melatonin rhythm in the BM, but not in the spleen, follows P-AA-NAT daily variation. In BM cells, LPS and IL10 induced an increase in melatonin levels associated with the increased expressions of P-AA-NAT and ASMT. In spleen cells, LPS induced an increase in the expression of P-AA-NAT but not of melatonin. Conversely, IL10 induced a significant increase in melatonin production associated with increased AA-NAT/P-AA-NAT expressions. In conclusion, BM and spleen cells present different profiles of circadian production of local melatonin and responses to immune signals.


  • Open Access

    Consequences of the Lack of IL-10 in Different Endotoxin Effects and its Relationship With Glucocorticoids

    by Marlina O. Córdoba-Moreno, María Florencia Todero, Adriana Fontanals, Gonzalo Pineda, Montagna Daniela, Noemí Yokobori, María Victoria Ramos, Gabriela Barrientos, Jorge E. Toblli, Martín A. Isturiz, et al.

    Sepsis constitutes one of the major causes of death in ICUs. In sepsis induced by gram-negative, although lipopolysaccharide (LPS) initially induces an exacerbated secretion of proinflammatory cytokines leading to endotoxic shock and death resembling a septic shock, it is also capable of inducing refractoriness to subsequent challenge with LPS, a state known as endotoxin tolerance, which is considered the initial step of the immunosuppression found in septic patients. As we previously demonstrated the importance of glucocorticoids in endotoxin tolerance, the aim of this study was to evaluate the contribution of Interleukin-10 (IL-10) both in the endotoxicshock and in the development of the tolerance and its relationship with glucocorticoids. Our results show that, upon LPS challenge, IL-10 knockout mice (KO) mice had an enhanced LPS sensitivity, along with elevated levels of proinflammatory cytokines as tumor necrosis factor-α, IL-12 and interferon-γ, and enhanced tissue damage, despite the high levels of glucocorticoids. This effect may be because, in part, of the higher expression of tumor necrosis factor receptors in IL-10 KO mice. Further, the injection of dexamethasone did not protect IL-10 KO mice from a LPS lethal challenge. Although tolerance was achieved in the absence of IL-10, it was weaker and the elevated levels of glucocorticoids were not able to reverse the high sensitivity of IL-10 KO mice to LPS. Nevertheless, glucocorticoids would play a pivotal role in the establishment and maintenance of this partial tolerance in IL-10 KO mice. Finally, our results show that IL-10 and glucocorticoids could act in a bidirectional way influencing the inflammatory and anti-inflammatory periods.


  • Open Access

    Formation of Foamy Macrophages by Tuberculous Pleural Effusions Is Triggered by the Interleukin-10/Signal Transducer and Activator of Transcription 3 Axis through ACAT Upregulation

    by Melanie Genoula, José Luis Marín Franco, Maeva Dupont, Denise Kviatcovsky, Ayelén Milillo, Pablo Schierloh, Eduardo Jose Moraña, Susana Poggi, Domingo Palmero, Dulce Mata-Espinosa, et al.

    The ability of Mycobacterium tuberculosis (Mtb) to persist in its human host relies on numerous immune evasion strategies, such as the deregulation of the lipid metabolism leading to the formation of foamy macrophages (FM). Yet, the specific host factors leading to the foamy phenotype of Mtb-infected macrophages remain unknown. Herein, we aimed to address whether host cytokines contribute to FM formation in the context of Mtb infection. Our approach is based on the use of an acellular fraction of tuberculous pleural effusions (TB-PE) as a physiological source of local factors released during Mtb infection. We found that TB-PE induced FM differentiation as observed by the increase in lipid bodies, intracellular cholesterol, and expression of the scavenger receptor CD36, as well as the enzyme acyl CoA:cholesterol acyl transferase (ACAT). Importantly, interleukin-10 (IL-10) depletion from TB-PE prevented the augmentation of all these parameters. Moreover, we observed a positive correlation between the levels of IL-10 and the number of lipid-laden CD14+ cells among the pleural cells in TB patients, demonstrating that FM differentiation occurs within the pleural environment. Downstream of IL-10 signaling, we noticed that the transcription factor signal transducer and activator of transcription 3 was activated by TB-PE, and its chemical inhibition prevented the accumulation of lipid bodies and ACAT expression in macrophages. In terms of the host immune response, TB-PE-treated macrophages displayed immunosuppressive properties and bore higher bacillary loads. Finally, we confirmed our results using bone marrow-derived macrophage from IL-10−/− mice demonstrating that IL-10 deficiency partially prevented foamy phenotype induction after Mtb lipids exposure. In conclusion, our results evidence a role of IL-10 in promoting the differentiation of FM in the context of Mtb infection, contributing to our understanding of how alterations of the host metabolic factors may favor pathogen persistence.


  • Open Access

    Novel Use of All-Trans-Retinoic Acid in A Model of Lipopolysaccharide-Immunosuppression to Decrease the Generation of Myeloid-Derived Suppressor Cells by Reducing the Proliferation of CD34+ Precursor Cells

    by Daiana Martire-Greco, Nahuel Rodriguez-Rodrigues, Luis A. Castillo, María Belén Vecchione, Marcelo de Campos-Nebel, Marlina Córdoba Moreno, Roberto Meiss, Mónica Vermeulen, Veronica I. Landoni, Gabriela C. Fernandez

    All-trans-retinoic acid (ATRA) is a derivative of vitamin A with antiproliferative properties. Endotoxin shock and subsequent immunosuppression (IS) by lipopolysaccharide (LPS) stimulates myelopoiesis with expansion of myeloid-derived suppressor cells (MDSC). Since we have previously shown that ATRA reverses the IS state by decreasing functional MDSC, our aim was to investigate if ATRA was able to modulate MDSC generation by regulating myelopoiesis in murine hematopoietic organs. We found that ATRA administration in vivo and in vitro decreased the number of CD34+ precursor cells that were increased in IS mice. When we studied the cellular mechanisms involved, we did not find any differences in apoptosis of CD34+ precursors or in the differentiation of these cells to their mature counterparts. Surprisingly, ATRA decreased precursor proliferation, in vitro and in vivo, as assessed by a reduction in the size and number of colony forming units generated from CD34+ cells and by a decreased incorporation of 3H-thymidine. Moreover, ATRA administration to IS mice decreased the number of MDSC in the spleen, with a restoration of T lymphocyte proliferation and a restitution of the histological architecture. Our results indicate, for the first time, a new use of ATRA to abolish LPS-induced myelopoiesis, affecting the proliferation of precursor cells, and in consequence, decreasing MDSC generation, having a direct impact on the improvement of immune competence. Administration of ATRA could overcome the immunosuppressive state generated by sepsis that often leads to opportunistic life-threatening infections. Therefore, ATRA could be considered a complementary treatment to enhance immune responses.